To include your compound in the COVID-19 Resource Center, submit it here.

FDA approves BMS's Yervoy in pediatric melanoma

FDA approved a label expansion for Yervoy ipilimumab (BMS-734016) from Bristol-Myers

Read the full 115 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE